ELIZABETH WELCH: Open Payments
NPI 1588119176 · ELLISVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 11 payments from 7 companies in 2025. Trend: 2023 $264 · 2024 $376 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Lilly USA, LLC | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $26 |
| Novo Nordisk Inc | 1 | $18 |
Products named: FARXIGA, UBRELVY, TRINTELLIX, FREESTYLE LIBRE 3, QULIPTA, MOUNJARO, ZEPBOUND, TRELEGY ELLIPTA.
Industry payments across MS — which companies pay providers there.
